Systemic bioavailability of ocularly applied 1% atropine eyedrops.

Author: KailaT, KorteJ M, SaariK M

Paper Details 
Original Abstract of the Article :
PURPOSE: To investigate the pharmacological basis of systemic effects of atropine eyedrops, we estimated the bioavailability of ophthalmic 1% atropine solution in healthy volunteers. METHODS: In a randomized crossover study we administered 0.3 mg atropine either intravenously or ocularly to six hea...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元:
https://doi.org/10.1034/j.1600-0420.1999.770215.x

データ提供:米国国立医学図書館(NLM)

The Systemic Reach of Ocular Atropine

Atropine, a widely used medication for eye conditions, has been traditionally considered to have primarily local effects. However, this research challenges that assumption by investigating the systemic bioavailability of ocularly applied 1% atropine eyedrops. The study aimed to quantify the absorption of atropine into the bloodstream after ocular administration and determine its potential for causing systemic side effects. Researchers found that a significant proportion of atropine applied to the eyes can be absorbed into the bloodstream, leading to systemic effects.

Systemic Bioavailability of Ocular Atropine

The study's findings demonstrate that ocularly applied atropine can have significant systemic bioavailability, reaching levels comparable to intravenous administration. This challenges the traditional view that atropine is a purely local drug. It's like discovering that a seemingly isolated oasis in a desert is actually connected to a vast underground network of water sources. This knowledge is crucial for understanding the potential side effects of ocular atropine and for guiding treatment strategies.

Implications for Ocular Atropine Use

The study's findings have implications for the safe and effective use of ocular atropine. Healthcare professionals should be aware of the potential for systemic side effects, particularly in patients with pre-existing conditions that could be exacerbated by atropine's anticholinergic effects. It's like navigating a desert landscape with a clear understanding of the potential dangers and challenges that lie ahead.

Dr. Camel's Conclusion

This study provides a valuable reminder that even medications intended for local use can have systemic effects. Understanding the systemic bioavailability of ocular atropine is essential for ensuring patient safety and optimizing treatment outcomes. It's like uncovering a hidden truth in a desert, shedding light on the complex nature of drug absorption and distribution.

Date :
  1. Date Completed 1999-06-07
  2. Date Revised 2022-04-10
Further Info :

Pubmed ID

10321537

DOI: Digital Object Identifier

10.1034/j.1600-0420.1999.770215.x

Related Literature

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.